This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on april 29, 2016.The sample was not returned for evaluation.A retention sample with the same product code/lot number combination was obtained.Visual inspection was performed on the unit and it was confirmed to not have any damage or anomalies anywhere on the device.Review of the device history records revealed no manufacturing issues.A definitive root cause could not be determined; therefore, this complaint is not confirmed.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|